Dr. Hsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
.
Lexington, MA 02420- Is this information wrong?
Education & Training
- Johns Hopkins University School of MedicineResidency, Internal Medicine, 1995 - 1998
- Perelman School of Medicine at the University of PennsylvaniaClass of 1995
Certifications & Licensure
- PA State Medical License 2005 - 2022
- MA State Medical License 1998 - 2023
Publications & Presentations
PubMed
- Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment.Hélène Bonnevaux, Stephane Guerif, Jana Albrecht, Erwan Jouannot, Thibaud De Gallier, Christian Beil, Christian M. Lange, Wulf Dirk Leuschner, M. Schneider, Cendrine L...> ;OncoImmunology. 2021 Aug 31
- 58 citationsPhase I trial of isatuximab monotherapy in the treatment of refractory multiple myeloma.Thomas Martin, Stephen A. Strickland, Martha Glenn, Eric Charpentier, Hélène Guillemin, Karl Hsu, Joseph Mikhael> ;Blood Cancer Journal. 2019 Mar 29
- 37 citationsThe role and regulation of friend of GATA-1 (FOG-1) during blood development in the zebrafish.Julio D. Amigo, Gabriele E. Ackermann, John J. Cope, Ming Yu, Jeffrey D. Cooney, Dongdong Ma, Nathaniel B. Langer, Ebrahim Shafizadeh, George C. Shaw, Wyatt Horsely, N...> ;Blood. 2009 Nov 19
- Join now to see all
Press Mentions
- Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate UpdatesAugust 14th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: